Accelero Capital Revenue and Competitors
Estimated Revenue & Valuation
- Accelero Capital's estimated annual revenue is currently $780k per year.
- Accelero Capital's estimated revenue per employee is $78,000
Employee Data
- Accelero Capital has 10 Employees.
- Accelero Capital grew their employee count by -17% last year.
Accelero Capital's People
| Name | Title | Email/Phone |
|---|
Accelero Capital Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.7M | 26 | -4% | $15.7M | N/A |
#2 | $1.4M | 21 | -50% | $21.2M | N/A |
#3 | $41.9M | 293 | 8% | $6M | N/A |
#4 | $6M | 53 | -22% | $216.8M | N/A |
#5 | $0M | 2 | 0% | $33.3M | N/A |
#6 | $26M | 182 | 0% | N/A | N/A |
#7 | $30.9M | 221 | -26% | $64.6M | N/A |
#8 | $28.6M | 205 | -22% | $46.8M | N/A |
#9 | $249.1M | 1340 | 15% | $75M | N/A |
#10 | $12.4M | 95 | 3% | N/A | N/A |
What Is Accelero Capital?
Accelero Capital is an investment and management group focused on telecommunication, digital media and technology. Accelero Capital`s management team has an unparalleled track record in strategic, operational and financial management. It leverages its expertise and sector know-how to identify high-growth assets and assets with turnaround potential.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$780k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Accelero Capital News
2022-04-13 - Global Aptamers: Therapeutics, Technologies and Services ...
2bind; Accelero Bioanalytics; Achiko; Acuitas Capital; Admera Health; Aju IB; Allergan; Amgen; ASKA Pharmaceutical; AstraZeneca; blueconic...
2022-04-06 - Global Targeted Protein Degradation (TPD) Market ...
... Venture capital financing of TPD technology companies ... AbbVie; Accelero Biostructures; Amgen; Amphista Therapeutics; AnHorn Medicines...
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.8M | 10 | -17% | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $1.5M | 10 | N/A | N/A |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $1.5M | 10 | N/A | N/A |